pantothenic acid has been researched along with Acute Confusional Senile Dementia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Begley, P; Church, S; Cooper, GJS; Faull, RLM; Patassini, S; Unwin, RD; Waldvogel, HJ; Xu, J | 1 |
| Erbas, O; Erdogan, MA; Taskıran, D; Yigitturk, G | 1 |
| Friede, T; Kieser, M; Röhmel, J | 1 |
| Otomo, E | 1 |
| Hasegawa, K | 1 |
| Nakahiro, M; Yoshida, H | 1 |
6 other study(ies) available for pantothenic acid and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Cerebral deficiency of vitamin B5 (d-pantothenic acid; pantothenate) as a potentially-reversible cause of neurodegeneration and dementia in sporadic Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Chemistry; Case-Control Studies; Female; Humans; Male; Middle Aged; Pantothenic Acid | 2020 |
Neuroprotective effects of dexpanthenol on streptozotocin-induced neuronal damage in rats.
Topics: Alzheimer Disease; Animals; Choline O-Acetyltransferase; Disease Models, Animal; Hippocampus; Humans; Maze Learning; Memory Disorders; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Pantothenic Acid; Rats; Rats, Sprague-Dawley; Rats, Wistar; Streptozocin; Tumor Necrosis Factor-alpha | 2022 |
Power and sample size determination when assessing the clinical relevance of trial results by 'responder analyses'.
Topics: Activities of Daily Living; Alzheimer Disease; Clinical Trials as Topic; Cognition; Cysteine; Drug Combinations; Humans; Pantothenic Acid; Risk Assessment; Sample Size; Treatment Outcome | 2004 |
[Drug therapy of Alzheimer's disease. General concepts on nootropic drugs].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amantadine; Aminoacridines; Dementia; gamma-Aminobutyric Acid; Humans; Pantothenic Acid; Tacrine | 1988 |
[Therapeutic application of cerebral metabolism enhancers to Alzheimer's disease and their limitations].
Topics: Alzheimer Disease; Brain; Energy Metabolism; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Oxygen Consumption; Pantothenic Acid | 1988 |
The "antidementia drug" pantoyl-gamma-aminobutyric acid increases high affinity uptake of choline by slices of rat brain.
Topics: Alzheimer Disease; Animals; Brain; Calcium; Cerebral Cortex; Choline; Corpus Striatum; gamma-Aminobutyric Acid; Hippocampus; In Vitro Techniques; Male; Pantothenic Acid; Potassium; Rats; Rats, Inbred Strains | 1986 |